LLLihua Li

Lihua Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lihua Li has a total of 73 co-authors. Here are the top co-authors by number of shared publications:

  • Lingling Chen

    Guangdong Key Lab of Orthopedic Technology and Implant Materials, Key Laboratory of Trauma & Tissue Repair of Tropical Area of PLA, Orthopedic Center, General Hospital of Southern Theater Command of PLA, Guangzhou, China

    6 shared publications
  • Xingyi Xu

    State Key Laboratory of Luminescent Materials and Devices, Guangdong Provincial Key Laboratory of Fiber Laser Materials and Applied Techniques, School of Materials Science and Engineering, School of Physics, South China University of Technology, Guangzhou 510640, China

    6 shared publications
  • Xianfeng Yang

    State Key Laboratory of Luminescent Materials and Devices, Guangdong Provincial Key Laboratory of Fiber Laser Materials and Applied Techniques, School of Materials Science and Engineering, School of Physics, South China University of Technology, Guangzhou 510640, China

    5 shared publications
  • Yao Lu

    Department of Joint and Orthopedics, Orthopedic Center Zhujiang Hospital, Southern Medical University, Guangzhou Guangdong People's Republic of China

    5 shared publications
  • Yao Lu

    Zhujiang Hospital, Guangzhou, China

    5 shared publications
  • Zhongmin Yang

    Future Institute of Technology Guangdong Provincial Key Laboratory of Nanophotonic Functional Materials and Devices Guangdong Basic Research Center of Excellence for Structure and Fundamental Interactions of Matter School of Optoelectronic Science and Engineering South China Normal University Guangzhou People's Republic of China

    5 shared publications

Latest Publications

  • Open Access

    Luminescent metal-organic frameworks for odor sensing and bionic olfactory receptors: Mechanisms, design, and applications

    by Yuzhi Qin, Lihua Li

    Luminescent metal-organic frameworks (LMOFs) combine the multi-response informational properties of optics and the high porosity, and tunability properties of framework materials. They exhibit behavior similar to that of neuronal olfactory receptors (ORs) in terms of their structure and signal response properties, therefore making them a promising candidate materials for the construction of bionic olfactory systems. The sensitive and diverse responses of LMOFs to the composition and concentration of gaseous environments originate from their ordered porous structures, tunable and diverse luminescent sensing pathways, and host-guest interaction behaviors, enabling their widespread application in the construction of bionic olfactory systems for environmental and industrial monitoring, breath and biomarker detection, the food industry, and high-risk environments. This paper adopts a bottom-up perspective to systematically review design strategies for bionic ORs from the standpoint of functional group sensitivity in odor molecules. These strategies include methods for the preparation and modulation of LMOFs, signal transduction mechanisms, and luminescent sensing pathways, as well as the diverse design and material selection of ORs. This perspective not only offers new insights into the design and selection of odor-sensing materials but also provides a reference and basis for the design of bionic olfactory systems through the intrinsic connection between microscopic luminescent sensing mechanisms and signal transduction mechanisms. This paper provides a review and discusses the prospects for the design of bionic olfactory ORs, promoting the development of this field from basic research on sensor materials toward application-oriented bionic olfactory systems, and extending the transition from artificial intelligence to embodied intelligence to the field of olfaction.

  • Open Access

    Real‐time biosensing of Parkinson's disease biomarkers via NIR‐activated upconversion nanoparticles

    by Jialin Liu, Nan Li, Yu Chen, Rui Pu, Wei Wei, Yunqi Lin, Lejing Li, Yao Lu, Jianhua Hao, Lihua Li

    Parkinson's disease (PD) is a progressive neurodegenerative disorder with incompletely understood pathophysiology, necessitating advanced tools for long‐term dynamic biomarker monitoring. Current techniques lack noninvasive platforms capable of real‐time multiparametric monitoring with high stability, sensitivity, and responsiveness. Here, we engineered core‐shell‐shell lanthanide‐doped upconversion nanoparticles (cssUCNPs) through controlled Tm 3+ /Er 3+ gradient doping and crystal field symmetry modulation. This “sandwich” heterostructure design suppressed cross‐relaxation, while Ca 2+ doping enhanced radiative transition efficiency. These modifications yielded a quantum yield improvement from 0.35 ± 0.014% to 3.27 ± 0.067%, representing a 9.3‐fold enhancement, alongside a fluorescence intensity increase of 425.5‐fold. The cssUCNPs exhibited exceptional photostability (>10,000 excitation cycles) and biocompatibility (>95% cell viability). Upon integration of Fluo4 with UCNPs, the system harnessed the luminescence resonance energy transfer effect to enable dual‐responsive sensing of Ca 2+ (detection limit: 1 μM) and temperature (sensitivity: 0.5 K −1 ), thereby facilitating long‐term tracing of Ca 2+ and temperature dynamics across PD pathological stages. Our results revealed that early‐phase PD is characterized by rapid Ca 2+ and temperature surges, followed by oscillatory fluctuations in the middle phase, and eventual stabilization at elevated levels in the terminal phase. These dynamic profiles establish a direct link between mitochondrial dysfunction and Ca 2+ dysregulation, highlighting Ca 2+ flow‐sensitive and thermally sensitive therapeutic targets for PD intervention.

  • Open Access

    Lanthanide-doped nanoparticles: An emerging platform for theranostic applications in neurodegenerative diseases

    by Jialin Liu, Lihua Li

    Lanthanide-doped nanoparticles (LNPs) offer an emerging non-invasive theranostic platform for monitoring and treating neurodegenerative diseases (NDs) own to their high optical stability, deep tissue penetration, and excellent biocompatibility. Their key advantage lies in the ability to produce upconversion or downshifting luminescence under near-infrared excitation, enabling high-resolution deep-tissue imaging and in situ monitoring, particularly suitable for tracking pathological progression and studying molecular interactions in disorders such as Alzheimer’s disease and Parkinson’s disease. By integrating functional components such as organic dyes, noble metal nanoparticles, or therapeutic agents, LNPs can be engineered into multifunctional theranostic nanoplatforms capable of simultaneous diagnosis and targeted therapy. Moreover, their precisely tunable emission properties open new avenues for deep-brain imaging and optical modulation. This review systematically summarizes the luminescence mechanisms of LNPs and recent advances in their applications for biosensing and diagnosis in NDs. It covers the detection of key biomarkers, including metal ions, nucleic acids, proteins, and reactive oxygen species. The discussion further extends to the therapeutic strategies targeting intracellular and microenvironmental factors, as well as synergistic approaches, with a particular emphasis on the role of LNPs in targeted drug delivery and combined theranostics. Finally, the review discusses future prospects for leveraging this platform to improve clinical outcomes in NDs.

  • Open Access

    Correction: Hydrophobic Carbon Dots Prevent α‐Synucleinopathy and Suppress Neuroinflammation to Treat Parkinson's Disease

    by Lihua Li, Yao Lu, Xiangling Ye, Chi Zhang, Jialin Liu, Zhongmin Yang, Jianhua Hao

    The aggregation of α‐synuclein (ɑ‐syn) coupled with overexpressed neuroinflammation instigates the degeneration of dopaminergic neurons, thereby aggravating the progression of Parkinson's disease (PD). Herein, we introduced a series of hydrophobic amino acid‐based carbon dots (CDs) for inhibiting ɑ‐syn aggregation and mitigating the inflammation in PD neurons. Significantly, we show that phenylalanine CDs (Phe‐CDs) could strongly bind with ɑ‐syn monomers and dimers via hydrophobic force, maintain their stability, and inhibit their further aggregation in situ and in vitro, finally conferring neuroprotection in PD by rescuing synaptic loss, ameliorating mitochondrial dysfunctions, and modulating Ca 2+ flux. Importantly, Phe‐CDs demonstrate the ability to penetrate the blood–brain barrier, significantly improving motor performance in PD mice. Our findings suggest that Phe‐CDs hold great promise as a therapeutic agent for PD and the related neurodegenerative disease.


  • Open Access

    Hydrophobic Carbon Dots Prevent α‐Synucleinopathy and Suppress Neuroinflammation to Treat Parkinson's Disease

    by Lihua Li, Yao Lu, Xiangling Ye, Chi Zhang, Jialin Liu, Zhongmin Yang, Jianhua Hao

    The aggregation of α‐synuclein (ɑ‐syn) coupled with overexpressed neuroinflammation instigates the degeneration of dopaminergic neurons, thereby aggravating the progression of Parkinson's disease (PD). Herein, we introduced a series of hydrophobic amino acid–based carbon dots (CDs) for inhibiting ɑ‐syn aggregation and mitigating the inflammation in PD neurons. Significantly, we show phenylalanine CDs (Phe‐CDs) could strongly bind with ɑ‐syn monomers and dimers via hydrophobic force, maintain their stability, and inhibit their further aggregates in situ and in vitro, finally conferring neuroprotection in PD by rescuing synaptic loss, ameliorating mitochondrial dysfunctions, and modulating Ca2+ flux. Importantly, Phe‐CDs demonstrate the ability to penetrate the blood–brain barrier (BBB), significantly improving motor performance in PD mice. Our findings suggest that Phe‐CDs hold great promise as a therapeutic agent for PD and the relative neurodegenerative disease.


  • Open Access

    A novel Anti-ROS osteoblast-specific delivery system for ankylosing spondylitis treatment via suppression of both inflammation and pathological new bone formation

    by Guan Zheng, Xiaoshuai Peng, Yunhui Zhang, Peng Wang, Zhongyu Xie, Jinteng Li, Wenjie Liu, Guiwen Ye, Yucong Lin, Guojian Li, et al.

    Ankylosing spondylitis (AS) is a common rheumatic disorder distinguished by chronic inflammation and heterotopic ossification at local entheses sites. Currently available medications, including nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs) and TNF inhibitors, are limited by side effects, high costs and unclear inhibitory effects on heterotopic ossification. Herein, we developed manganese ferrite nanoparticles modified by the aptamer CH6 (CH6-MF NPs) that can efficiently scavenge ROS and actively deliver siRNA into hMSCs and osteoblasts in vivo for effective AS treatment. CH6-MF NPs loaded with BMP2 siRNA (CH6-MF-Si NPs) effectively suppressed abnormal osteogenic differentiation under inflammatory conditions in vitro. During their circulation and passive accumulation in inflamed joints in the Zap70mut mouse model, CH6-MF-Si NPs attenuated local inflammation and rescued heterotopic ossification in the entheses. Thus, CH6-MF NPs may be an effective inflammation reliever and osteoblast-specific delivery system, and CH6-MF-Si NPs have potential for the dual treatment of chronic inflammation and heterotopic ossification in AS.


  • Top Cited Papers

    Copper Doped Carbon Dots for Addressing Bacterial Biofilm Formation, Wound Infection, and Tooth Staining

    by Meng Liu, Ling Huang, Xingyi Xu, Xiaoming Wei, Xianfeng Yang, Xiaolei Li, Bingnan Wang, Yue Xu, Lihua Li, Zhongmin Yang

    Oral infectious diseases and tooth staining, the main challenges of dental healthcare, are inextricably linked to microbial colonization and the formation of pathogenic biofilms. However, dentistry has so far still lacked simple, safe, and universal prophylactic options and therapy. Here, we report copper-doped carbon dots (Cu-CDs) that display enhanced catalytic (catalase-like, peroxidase-like) activity in the oral environment for inhibiting initial bacteria (Streptococcus mutans) adhesion and for subsequent biofilm eradication without impacting the surrounding oral tissues via oxygen (O2) and reactive oxygen species (ROS) generation. Especially, Cu-CDs exhibit strong affinity for lipopolysaccharides (LPS) and peptidoglycans (PGN), thus conferring them with excellent antibacterial ability against Gram-positive bacteria (Staphylococcus aureus) and Gram-negative bacteria (Escherichia coli), such that they can prevent wound purulent infection and promoting rapid wound healing. Additionally, the Cu-CDs/H2O2 system shows a better performance in tooth whitening, compared with results obtained with other alternatives, e.g., CDs and clinically used H2O2, particularly its negligible enamel and dentin destruction. It is anticipated that the biocompatible Cu-CDs presented in this work are a promising nano-mouthwash for eliminating oral pathogenic biofilms, prompting wound healing as well as tooth whitening, highlighting their significance in oral health management.


  • Open Access

    Conducting molybdenum sulfide/graphene oxide/polyvinyl alcohol nanocomposite hydrogel for repairing spinal cord injury

    by Lingling Chen, Wanshun Wang, Zefeng Lin, Yao Lu, Hu Chen, Binglin Li, Zhan Li, Hong Xia, Lihua Li, Tao Zhang

    A sort of composite hydrogel with good biocompatibility, suppleness, high conductivity, and anti-inflammatory activity based on polyvinyl alcohol (PVA) and molybdenum sulfide/graphene oxide (MoS2/GO) nanomaterial has been developed for spinal cord injury (SCI) restoration. The developed (MoS2/GO/PVA) hydrogel exhibits excellent mechanical properties, outstanding electronic conductivity, and inflammation attenuation activity. It can promote neural stem cells into neurons differentiation as well as inhibit the astrocytes development in vitro. In addition, the composite hydrogel shows a high anti-inflammatory effect. After implantation of the composite hydrogel in mice, it could activate the endogenous regeneration of the spinal cord and inhibit the activation of glial cells in the injured area, thus resulting in the recovery of locomotor function. Overall, our work provides a new sort of hydrogels for SCI reparation, which shows great promise for improving the dilemma in SCI therapy. Graphical Abstract


  • Open Access

    Biocompatible tellurium nanoneedles with long-term stable antibacterial activity for accelerated wound healing

    by Ling Huang, Meng Liu, Zhibin Feng, Xingyi Xu, Lingling Chen, Zhijun Ma, Lihua Li


  • Immunotherapy for Tumor Metastasis by Artificial Antigen-Presenting Cells via Targeted Microenvironment Regulation and T-Cell Activation

    by Yao Lu, Lihua Li, Jingwen Du, Jieli Chen, Xingyi Xu, Xianfeng Yang, Changhai Ding, Chuanbin Mao

    Effective expansion of T-cells without ex vivo stimulation and maintenance of their antitumor functions in the complex tumor microenvironment (TME) are still daunting challenges in T-cell-based immunotherapy. Here, we developed biomimetic artificial antigen-presenting cells (aAPCs), ultrathin MnOx nanoparticles (NPs) functionalized with T-cell activators (anti-CD3/CD28 mAbs, CD), and tumor cell membranes (CMs) for enhanced lung metastasis immunotherapy. The aAPCs, termed CD-MnOx@CM, not only efficiently enhanced the expansion and activation of intratumoral CD8+ cytotoxic T-cells and dendritic cells after homing to homotypic metastatic tumors but also regulated the TME to facilitate T-cell survival through catalyzing the decomposition of intratumoral H2O2 into O2. Consequently, the aAPCs significantly inhibited the development of lung metastatic nodules and extended the survival of a B16–F10 melanoma metastasis model, while minimizing adverse events. Our work represents a new biomaterial strategy of inhibiting tumor metastasis through targeted TME regulation and in situ T-cell-based immunotherapy.